TVTX - Company ID 0001438533
As of 2026-09-07, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $6.07 B, making it the #1282 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $6.07 B |
| 2026-09-06 | $6.07 B |
| 2026-09-05 | $6.07 B |
| 2026-09-04 | $6.07 B |
| 2026-09-03 | $6.17 B |
| 2026-09-02 | $6.25 B |
| 2026-09-01 | $6.11 B |
| 2026-08-31 | $6.16 B |
| 2026-08-30 | $6.11 B |
| 2026-08-29 | $6.11 B |
| 2026-08-28 | $6.12 B |
| 2026-08-27 | $6.28 B |
As of 2026-09-07, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $6.07 B, making it the #1282 most valuable US-listed company.
Travere Therapeutics, Inc. is the #1282 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $6.24 B |
| 2026-08-25 | $6.23 B |
| 2026-08-24 | $6.06 B |
| 2026-08-23 | $6.11 B |
| 2026-08-22 | $6.11 B |
| 2026-08-21 | $6.11 B |
| 2026-08-20 | $5.99 B |
| 2026-08-19 | $6.13 B |
| 2026-08-18 | $5.90 B |
| 2026-08-17 | $5.90 B |
| 2026-08-16 | $5.78 B |
| 2026-08-15 | $5.78 B |
| 2026-08-14 | $5.78 B |
| 2026-08-13 | $5.71 B |
| 2026-08-12 | $5.78 B |
| 2026-08-11 | $5.60 B |
| 2026-08-10 | $5.67 B |
| 2026-08-09 | $5.70 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.